Back to Search
Start Over
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma.
- Source :
- Journal of Clinical Oncology; 1/1/2024, Vol. 42 Issue 1, p26-37, 21p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 42
- Issue :
- 1
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 174389326
- Full Text :
- https://doi.org/10.1200/JCO.23.01696